Association of Hysterectomy and Invasive Epithelial Ovarian and Tubal Cancer: a Cohort Study Within UKCTOCS

Overview

Journal BJOG

Specialty Gynecology & Obstetrics

Date 2021 Sep 23

PMID 34555263

Citations 1

Authors

J A Taylor

M Burnell

A Ryan

C Karpinskyj

J K Kalsi

H Taylor

S Apostolidou

A Sharma

R Manchanda

R Woolas

S Campbell

M Parmar

N Singh

I J Jacobs

U Menon

A Gentry-Maharaj

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the association between hysterectomy with conservation of one or both adnexa and ovarian and tubal cancer.

Design: Prospective cohort study.

Setting: Thirteen NHS Trusts in England, Wales and Northern Ireland.

Population: A total of 202 506 postmenopausal women recruited between 2001 and 2005 to the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) and followed up until 31 December 2014.

Methods: Multiple sources (questionnaires, hospital notes, Hospital Episodes Statistics, national cancer/death registries, ultrasound reports) were used to obtain accurate data on hysterectomy (with conservation of one or both adnexa) and outcomes censored at bilateral oophorectomy, death, ovarian/tubal cancer diagnosis, loss to follow up or 31 December 2014. Cox proportional hazards regression models were used to assess the association.

Main Outcome Measures: Invasive epithelial ovarian and tubal cancer (WHO 2014) on independent outcome review.

Results: Hysterectomy with conservation of one or both adnexa was reported in 41 912 (20.7%; 41 912/202 506) women. Median follow up was 11.1 years (interquartile range 9.96-12.04), totalling >2.17 million woman-years. Among women who had undergone hysterectomy, 0.55% (231/41 912) were diagnosed with ovarian/tubal cancer, compared with 0.59% (945/160 594) of those with intact uterus. Multivariable analysis showed no evidence of an association between hysterectomy and invasive epithelial ovarian/tubal cancer (hazard ratio 0.98, 95% CI 0.85-1.13, P = 0.765).

Conclusions: This large cohort study provides further independent validation that hysterectomy is not associated with alteration of invasive epithelial ovarian and tubal cancer risk. These data are important both for clinical counselling and for refining risk prediction models.

Tweetable Abstract: Hysterectomy does not alter risk of invasive epithelial ovarian and tubal cancer.

Citing Articles

Tubal Cancer Clinical Management: Two Exceptional Scenarios and a Review of the Literature.

Colombi I, DIndinosante M, Lazzeri L, Zupi E, Pisaneschi S, Giusti M J Clin Med. 2024; 13(17).

PMID: 39274288 PMC: 11395798. DOI: 10.3390/jcm13175075.

References

Gentry-Maharaj A, Taylor H, Kalsi J, Ryan A, Burnell M, Sharma A . Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMJ Open. 2014; 4(3):e004421. PMC: 3939665. DOI: 10.1136/bmjopen-2013-004421. View

Elze M, Gregson J, Baber U, Williamson E, Sartori S, Mehran R . Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies. J Am Coll Cardiol. 2017; 69(3):345-357. DOI: 10.1016/j.jacc.2016.10.060. View

Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M . Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer. 1997; 71(6):948-51. DOI: 10.1002/(sici)1097-0215(19970611)71:6<948::aid-ijc6>3.0.co;2-y. View

Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P . The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet. 2016; 293(4):695-700. DOI: 10.1007/s00404-016-4035-8. View

Clyde M, Weber R, Iversen E, Poole E, Doherty J, Goodman M . Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol. 2016; 184(8):579-589. PMC: 5065620. DOI: 10.1093/aje/kww091. View

Jacobs I, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi J . Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2015; 387(10022):945-956. PMC: 4779792. DOI: 10.1016/S0140-6736(15)01224-6. View

Pearce C, Rossing M, Lee A, Ness R, Webb P, Chenevix-Trench G . Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2013; 22(5):880-90. PMC: 3963289. DOI: 10.1158/1055-9965.EPI-12-1030-T. View

Wang C, Liang Z, Liu X, Zhang Q, Li S . The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses. Int J Environ Res Public Health. 2016; 13(11). PMC: 5129348. DOI: 10.3390/ijerph13111138. View

Rice M, Murphy M, Vitonis A, Cramer D, Titus L, Tworoger S . Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study. Int J Cancer. 2013; 133(10):2415-21. PMC: 3772657. DOI: 10.1002/ijc.28249. View

10.

Li K, Husing A, Fortner R, Tjonneland A, Hansen L, Dossus L . An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study. Br J Cancer. 2015; 112(7):1257-65. PMC: 4385951. DOI: 10.1038/bjc.2015.22. View

11.

Gaudet M, Gapstur S, Sun J, Teras L, Campbell P, Patel A . Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Obstet Gynecol. 2014; 123(6):1247-1255. DOI: 10.1097/AOG.0000000000000270. View

12.

Menon U, Gentry-Maharaj A, Ryan A, Sharma A, Burnell M, Hallett R . Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ. 2008; 337:a2079. PMC: 2583394. DOI: 10.1136/bmj.a2079. View

13.

Wentzensen N, Poole E, Trabert B, White E, Arslan A, Patel A . Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol. 2016; 34(24):2888-98. PMC: 5012665. DOI: 10.1200/JCO.2016.66.8178. View

14.

Chiaffarino F, Parazzini F, Decarli A, Franceschi S, Talamini R, Montella M . Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol Oncol. 2005; 97(2):318-22. DOI: 10.1016/j.ygyno.2005.01.030. View

15.

Merritt M, De Pari M, Vitonis A, Titus L, Cramer D, Terry K . Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod. 2013; 28(5):1406-17. PMC: 3627336. DOI: 10.1093/humrep/des466. View

16.

Kurman R, Shih I . The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. Am J Pathol. 2016; 186(4):733-47. PMC: 5808151. DOI: 10.1016/j.ajpath.2015.11.011. View

17.

Jordan S, Nagle C, Coory M, Maresco D, Protani M, Pandeya N . Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis. Eur J Cancer. 2013; 49(17):3638-47. DOI: 10.1016/j.ejca.2013.07.005. View

18.

Polcher M, Hauptmann S, Fotopoulou C, Schmalfeldt B, Meinhold-Heerlein I, Mustea A . Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO. Arch Gynecol Obstet. 2015; 292(1):231-4. DOI: 10.1007/s00404-015-3697-y. View

19.

Dixon-Suen S, Webb P, Wilson L, Tuesley K, Stewart L, Jordan S . The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study. J Natl Cancer Inst. 2019; 111(10):1097-1103. PMC: 6792101. DOI: 10.1093/jnci/djz015. View

20.

Rice M, Murphy M, Tworoger S . Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. J Ovarian Res. 2012; 5(1):13. PMC: 3386864. DOI: 10.1186/1757-2215-5-13. View